Santen Pharmaceutical Co., Ltd.
Santen Pharmaceutical Co., Ltd. (SNPHY) Stock Competitors & Peer Comparison
See (SNPHY) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - General Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| SNPHY | $11.13 | +0.93% | 3.8B | 16.33 | $0.69 | N/A |
| RHHBY | $39.41 | +1.47% | 257.1B | 21.88 | $1.80 | +3.46% |
| RHHBF | $332.39 | -4.43% | 253.2B | 22.86 | $14.57 | +3.31% |
| RHHVF | $317.36 | +0.25% | 252.4B | 21.47 | $14.57 | +3.48% |
| AZNCF | $150.50 | +2.03% | 233.1B | 28.31 | $5.31 | +2.07% |
| NVSEF | $112.44 | -3.07% | 211.4B | 16.24 | $6.86 | +3.55% |
| SNYNF | $92.79 | +0.25% | 113.2B | 16.03 | $5.79 | +4.72% |
| BMYMP | $785.00 | +0.00% | 90B | 3488.89 | $0.23 | +0.13% |
| CHGCF | $52.05 | +1.88% | 85.5B | 31.87 | $1.63 | +2.26% |
| CHGCY | $24.81 | +1.01% | 81.9B | 30.73 | $0.81 | +2.15% |
Stock Comparison
SNPHY vs RHHBY Comparison August 2025
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.8B. In comparison, RHHBY has a market cap of 257.1B. Regarding current trading prices, SNPHY is priced at $11.13, while RHHBY trades at $39.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 16.33, whereas RHHBY's P/E ratio is 21.88. In terms of profitability, SNPHY's ROE is +0.12%, compared to RHHBY's ROE of +0.35%. Regarding short-term risk, SNPHY is less volatile compared to RHHBY. This indicates potentially lower risk in terms of short-term price fluctuations for SNPHY.Check RHHBY's competition here
SNPHY vs RHHBF Comparison August 2025
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.8B. In comparison, RHHBF has a market cap of 253.2B. Regarding current trading prices, SNPHY is priced at $11.13, while RHHBF trades at $332.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 16.33, whereas RHHBF's P/E ratio is 22.86. In terms of profitability, SNPHY's ROE is +0.12%, compared to RHHBF's ROE of +0.35%. Regarding short-term risk, SNPHY and RHHBF have similar daily volatility (0.00).Check RHHBF's competition here
SNPHY vs RHHVF Comparison August 2025
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.8B. In comparison, RHHVF has a market cap of 252.4B. Regarding current trading prices, SNPHY is priced at $11.13, while RHHVF trades at $317.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 16.33, whereas RHHVF's P/E ratio is 21.47. In terms of profitability, SNPHY's ROE is +0.12%, compared to RHHVF's ROE of +0.35%. Regarding short-term risk, SNPHY is less volatile compared to RHHVF. This indicates potentially lower risk in terms of short-term price fluctuations for SNPHY.Check RHHVF's competition here
SNPHY vs AZNCF Comparison August 2025
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.8B. In comparison, AZNCF has a market cap of 233.1B. Regarding current trading prices, SNPHY is priced at $11.13, while AZNCF trades at $150.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 16.33, whereas AZNCF's P/E ratio is 28.31. In terms of profitability, SNPHY's ROE is +0.12%, compared to AZNCF's ROE of +0.19%. Regarding short-term risk, SNPHY is less volatile compared to AZNCF. This indicates potentially lower risk in terms of short-term price fluctuations for SNPHY.Check AZNCF's competition here
SNPHY vs NVSEF Comparison August 2025
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.8B. In comparison, NVSEF has a market cap of 211.4B. Regarding current trading prices, SNPHY is priced at $11.13, while NVSEF trades at $112.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 16.33, whereas NVSEF's P/E ratio is 16.24. In terms of profitability, SNPHY's ROE is +0.12%, compared to NVSEF's ROE of +0.31%. Regarding short-term risk, SNPHY is less volatile compared to NVSEF. This indicates potentially lower risk in terms of short-term price fluctuations for SNPHY.Check NVSEF's competition here
SNPHY vs SNYNF Comparison August 2025
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.8B. In comparison, SNYNF has a market cap of 113.2B. Regarding current trading prices, SNPHY is priced at $11.13, while SNYNF trades at $92.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 16.33, whereas SNYNF's P/E ratio is 16.03. In terms of profitability, SNPHY's ROE is +0.12%, compared to SNYNF's ROE of +0.10%. Regarding short-term risk, SNPHY and SNYNF have similar daily volatility (0.00).Check SNYNF's competition here
SNPHY vs BMYMP Comparison August 2025
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.8B. In comparison, BMYMP has a market cap of 90B. Regarding current trading prices, SNPHY is priced at $11.13, while BMYMP trades at $785.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 16.33, whereas BMYMP's P/E ratio is 3488.89. In terms of profitability, SNPHY's ROE is +0.12%, compared to BMYMP's ROE of +0.32%. Regarding short-term risk, SNPHY is less volatile compared to BMYMP. This indicates potentially lower risk in terms of short-term price fluctuations for SNPHY.Check BMYMP's competition here
SNPHY vs CHGCF Comparison August 2025
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.8B. In comparison, CHGCF has a market cap of 85.5B. Regarding current trading prices, SNPHY is priced at $11.13, while CHGCF trades at $52.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 16.33, whereas CHGCF's P/E ratio is 31.87. In terms of profitability, SNPHY's ROE is +0.12%, compared to CHGCF's ROE of +0.17%. Regarding short-term risk, SNPHY is less volatile compared to CHGCF. This indicates potentially lower risk in terms of short-term price fluctuations for SNPHY.Check CHGCF's competition here
SNPHY vs CHGCY Comparison August 2025
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.8B. In comparison, CHGCY has a market cap of 81.9B. Regarding current trading prices, SNPHY is priced at $11.13, while CHGCY trades at $24.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 16.33, whereas CHGCY's P/E ratio is 30.73. In terms of profitability, SNPHY's ROE is +0.12%, compared to CHGCY's ROE of +0.17%. Regarding short-term risk, SNPHY is less volatile compared to CHGCY. This indicates potentially lower risk in terms of short-term price fluctuations for SNPHY.Check CHGCY's competition here
SNPHY vs GLAXF Comparison August 2025
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.8B. In comparison, GLAXF has a market cap of 77.1B. Regarding current trading prices, SNPHY is priced at $11.13, while GLAXF trades at $18.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 16.33, whereas GLAXF's P/E ratio is 17.37. In terms of profitability, SNPHY's ROE is +0.12%, compared to GLAXF's ROE of +0.22%. Regarding short-term risk, SNPHY is less volatile compared to GLAXF. This indicates potentially lower risk in terms of short-term price fluctuations for SNPHY.Check GLAXF's competition here
SNPHY vs DSNKY Comparison August 2025
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.8B. In comparison, DSNKY has a market cap of 46.1B. Regarding current trading prices, SNPHY is priced at $11.13, while DSNKY trades at $24.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 16.33, whereas DSNKY's P/E ratio is 23.79. In terms of profitability, SNPHY's ROE is +0.12%, compared to DSNKY's ROE of +0.18%. Regarding short-term risk, SNPHY is less volatile compared to DSNKY. This indicates potentially lower risk in terms of short-term price fluctuations for SNPHY.Check DSNKY's competition here
SNPHY vs DSKYF Comparison August 2025
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.8B. In comparison, DSKYF has a market cap of 45.2B. Regarding current trading prices, SNPHY is priced at $11.13, while DSKYF trades at $25.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 16.33, whereas DSKYF's P/E ratio is 23.46. In terms of profitability, SNPHY's ROE is +0.12%, compared to DSKYF's ROE of +0.18%. Regarding short-term risk, SNPHY is less volatile compared to DSKYF. This indicates potentially lower risk in terms of short-term price fluctuations for SNPHY.Check DSKYF's competition here
SNPHY vs BAYRY Comparison August 2025
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.8B. In comparison, BAYRY has a market cap of 31B. Regarding current trading prices, SNPHY is priced at $11.13, while BAYRY trades at $7.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 16.33, whereas BAYRY's P/E ratio is -8.31. In terms of profitability, SNPHY's ROE is +0.12%, compared to BAYRY's ROE of -0.10%. Regarding short-term risk, SNPHY is less volatile compared to BAYRY. This indicates potentially lower risk in terms of short-term price fluctuations for SNPHY.Check BAYRY's competition here
SNPHY vs OTSKY Comparison August 2025
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.8B. In comparison, OTSKY has a market cap of 26.5B. Regarding current trading prices, SNPHY is priced at $11.13, while OTSKY trades at $25.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 16.33, whereas OTSKY's P/E ratio is 9.84. In terms of profitability, SNPHY's ROE is +0.12%, compared to OTSKY's ROE of +0.03%. Regarding short-term risk, SNPHY is less volatile compared to OTSKY. This indicates potentially lower risk in terms of short-term price fluctuations for SNPHY.Check OTSKY's competition here
SNPHY vs OTSKF Comparison August 2025
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.8B. In comparison, OTSKF has a market cap of 23.4B. Regarding current trading prices, SNPHY is priced at $11.13, while OTSKF trades at $44.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 16.33, whereas OTSKF's P/E ratio is 8.71. In terms of profitability, SNPHY's ROE is +0.12%, compared to OTSKF's ROE of +0.03%. Regarding short-term risk, SNPHY and OTSKF have similar daily volatility (0.00).Check OTSKF's competition here
SNPHY vs ORINY Comparison August 2025
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.8B. In comparison, ORINY has a market cap of 22.9B. Regarding current trading prices, SNPHY is priced at $11.13, while ORINY trades at $41.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 16.33, whereas ORINY's P/E ratio is 26.77. In terms of profitability, SNPHY's ROE is +0.12%, compared to ORINY's ROE of +0.37%. Regarding short-term risk, SNPHY is less volatile compared to ORINY. This indicates potentially lower risk in terms of short-term price fluctuations for SNPHY.Check ORINY's competition here
SNPHY vs ALPMY Comparison August 2025
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.8B. In comparison, ALPMY has a market cap of 19B. Regarding current trading prices, SNPHY is priced at $11.13, while ALPMY trades at $10.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 16.33, whereas ALPMY's P/E ratio is 55.73. In terms of profitability, SNPHY's ROE is +0.12%, compared to ALPMY's ROE of +0.03%. Regarding short-term risk, SNPHY is less volatile compared to ALPMY. This indicates potentially lower risk in terms of short-term price fluctuations for SNPHY.Check ALPMY's competition here
SNPHY vs ALPMF Comparison August 2025
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.8B. In comparison, ALPMF has a market cap of 18.7B. Regarding current trading prices, SNPHY is priced at $11.13, while ALPMF trades at $10.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 16.33, whereas ALPMF's P/E ratio is 55.05. In terms of profitability, SNPHY's ROE is +0.12%, compared to ALPMF's ROE of +0.03%. Regarding short-term risk, SNPHY and ALPMF have similar daily volatility (0.00).Check ALPMF's competition here
SNPHY vs GIKLY Comparison August 2025
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.8B. In comparison, GIKLY has a market cap of 17.9B. Regarding current trading prices, SNPHY is priced at $11.13, while GIKLY trades at $7.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 16.33, whereas GIKLY's P/E ratio is 29.80. In terms of profitability, SNPHY's ROE is +0.12%, compared to GIKLY's ROE of +0.03%. Regarding short-term risk, SNPHY is less volatile compared to GIKLY. This indicates potentially lower risk in terms of short-term price fluctuations for SNPHY.Check GIKLY's competition here
SNPHY vs CSPCY Comparison August 2025
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.8B. In comparison, CSPCY has a market cap of 15.4B. Regarding current trading prices, SNPHY is priced at $11.13, while CSPCY trades at $5.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 16.33, whereas CSPCY's P/E ratio is 25.38. In terms of profitability, SNPHY's ROE is +0.12%, compared to CSPCY's ROE of +0.18%. Regarding short-term risk, SNPHY is less volatile compared to CSPCY. This indicates potentially lower risk in terms of short-term price fluctuations for SNPHY.Check CSPCY's competition here
SNPHY vs CHJTF Comparison August 2025
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.8B. In comparison, CHJTF has a market cap of 13.8B. Regarding current trading prices, SNPHY is priced at $11.13, while CHJTF trades at $1.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 16.33, whereas CHJTF's P/E ratio is 24.00. In terms of profitability, SNPHY's ROE is +0.12%, compared to CHJTF's ROE of +0.18%. Regarding short-term risk, SNPHY and CHJTF have similar daily volatility (0.00).Check CHJTF's competition here
SNPHY vs ORINF Comparison August 2025
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.8B. In comparison, ORINF has a market cap of 11.4B. Regarding current trading prices, SNPHY is priced at $11.13, while ORINF trades at $81.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 16.33, whereas ORINF's P/E ratio is 26.48. In terms of profitability, SNPHY's ROE is +0.12%, compared to ORINF's ROE of +0.37%. Regarding short-term risk, SNPHY and ORINF have similar daily volatility (0.00).Check ORINF's competition here
SNPHY vs RCDTF Comparison August 2025
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.8B. In comparison, RCDTF has a market cap of 10.1B. Regarding current trading prices, SNPHY is priced at $11.13, while RCDTF trades at $49.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 16.33, whereas RCDTF's P/E ratio is 22.07. In terms of profitability, SNPHY's ROE is +0.12%, compared to RCDTF's ROE of +0.22%. Regarding short-term risk, SNPHY is less volatile compared to RCDTF. This indicates potentially lower risk in terms of short-term price fluctuations for SNPHY.Check RCDTF's competition here
SNPHY vs GIFLF Comparison August 2025
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.8B. In comparison, GIFLF has a market cap of 8.5B. Regarding current trading prices, SNPHY is priced at $11.13, while GIFLF trades at $14.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 16.33, whereas GIFLF's P/E ratio is 28.00. In terms of profitability, SNPHY's ROE is +0.12%, compared to GIFLF's ROE of +0.03%. Regarding short-term risk, SNPHY and GIFLF have similar daily volatility (0.00).Check GIFLF's competition here
SNPHY vs GIFOF Comparison August 2025
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.8B. In comparison, GIFOF has a market cap of 8.4B. Regarding current trading prices, SNPHY is priced at $11.13, while GIFOF trades at $8.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 16.33, whereas GIFOF's P/E ratio is 16.50. In terms of profitability, SNPHY's ROE is +0.12%, compared to GIFOF's ROE of +0.03%. Regarding short-term risk, SNPHY is less volatile compared to GIFOF. This indicates potentially lower risk in terms of short-term price fluctuations for SNPHY.Check GIFOF's competition here
SNPHY vs KYKOF Comparison August 2025
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.8B. In comparison, KYKOF has a market cap of 8.4B. Regarding current trading prices, SNPHY is priced at $11.13, while KYKOF trades at $16.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 16.33, whereas KYKOF's P/E ratio is 32.65. In terms of profitability, SNPHY's ROE is +0.12%, compared to KYKOF's ROE of +0.08%. Regarding short-term risk, SNPHY and KYKOF have similar daily volatility (0.00).Check KYKOF's competition here
SNPHY vs DPHAY Comparison August 2025
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.8B. In comparison, DPHAY has a market cap of 5.6B. Regarding current trading prices, SNPHY is priced at $11.13, while DPHAY trades at $98.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 16.33, whereas DPHAY's P/E ratio is -155.56. In terms of profitability, SNPHY's ROE is +0.12%, compared to DPHAY's ROE of -0.04%. Regarding short-term risk, SNPHY and DPHAY have similar daily volatility (0.00).Check DPHAY's competition here
SNPHY vs OPHLY Comparison August 2025
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.8B. In comparison, OPHLY has a market cap of 5.3B. Regarding current trading prices, SNPHY is priced at $11.13, while OPHLY trades at $3.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 16.33, whereas OPHLY's P/E ratio is 15.52. In terms of profitability, SNPHY's ROE is +0.12%, compared to OPHLY's ROE of +0.06%. Regarding short-term risk, SNPHY is less volatile compared to OPHLY. This indicates potentially lower risk in terms of short-term price fluctuations for SNPHY.Check OPHLY's competition here
SNPHY vs OPHLF Comparison August 2025
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.8B. In comparison, OPHLF has a market cap of 5.2B. Regarding current trading prices, SNPHY is priced at $11.13, while OPHLF trades at $11.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 16.33, whereas OPHLF's P/E ratio is 15.63. In terms of profitability, SNPHY's ROE is +0.12%, compared to OPHLF's ROE of +0.06%. Regarding short-term risk, SNPHY and OPHLF have similar daily volatility (0.00).Check OPHLF's competition here
SNPHY vs PTKFF Comparison August 2025
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.8B. In comparison, PTKFF has a market cap of 4.4B. Regarding current trading prices, SNPHY is priced at $11.13, while PTKFF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 16.33, whereas PTKFF's P/E ratio is N/A. In terms of profitability, SNPHY's ROE is +0.12%, compared to PTKFF's ROE of +0.15%. Regarding short-term risk, SNPHY and PTKFF have similar daily volatility (0.00).Check PTKFF's competition here
SNPHY vs SNPHF Comparison August 2025
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.8B. In comparison, SNPHF has a market cap of 4.3B. Regarding current trading prices, SNPHY is priced at $11.13, while SNPHF trades at $12.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 16.33, whereas SNPHF's P/E ratio is 18.06. In terms of profitability, SNPHY's ROE is +0.12%, compared to SNPHF's ROE of +0.12%. Regarding short-term risk, SNPHY is less volatile compared to SNPHF. This indicates potentially lower risk in terms of short-term price fluctuations for SNPHY.Check SNPHF's competition here
SNPHY vs VRBCF Comparison August 2025
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.8B. In comparison, VRBCF has a market cap of 2.7B. Regarding current trading prices, SNPHY is priced at $11.13, while VRBCF trades at $324.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 16.33, whereas VRBCF's P/E ratio is 16.34. In terms of profitability, SNPHY's ROE is +0.12%, compared to VRBCF's ROE of +0.14%. Regarding short-term risk, SNPHY and VRBCF have similar daily volatility (0.00).Check VRBCF's competition here
SNPHY vs HAWPF Comparison August 2025
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.8B. In comparison, HAWPF has a market cap of 2.2B. Regarding current trading prices, SNPHY is priced at $11.13, while HAWPF trades at $10.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 16.33, whereas HAWPF's P/E ratio is 12.33. In terms of profitability, SNPHY's ROE is +0.12%, compared to HAWPF's ROE of +0.06%. Regarding short-term risk, SNPHY and HAWPF have similar daily volatility (0.00).Check HAWPF's competition here
SNPHY vs HAWPY Comparison August 2025
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.8B. In comparison, HAWPY has a market cap of 2B. Regarding current trading prices, SNPHY is priced at $11.13, while HAWPY trades at $35.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 16.33, whereas HAWPY's P/E ratio is 17.89. In terms of profitability, SNPHY's ROE is +0.12%, compared to HAWPY's ROE of +0.06%. Regarding short-term risk, SNPHY is less volatile compared to HAWPY. This indicates potentially lower risk in terms of short-term price fluctuations for SNPHY.Check HAWPY's competition here
SNPHY vs LYPHF Comparison August 2025
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.8B. In comparison, LYPHF has a market cap of 960M. Regarding current trading prices, SNPHY is priced at $11.13, while LYPHF trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 16.33, whereas LYPHF's P/E ratio is 12.76. In terms of profitability, SNPHY's ROE is +0.12%, compared to LYPHF's ROE of +0.06%. Regarding short-term risk, SNPHY is less volatile compared to LYPHF. This indicates potentially lower risk in terms of short-term price fluctuations for SNPHY.Check LYPHF's competition here
SNPHY vs CMOPF Comparison August 2025
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.8B. In comparison, CMOPF has a market cap of 876.6M. Regarding current trading prices, SNPHY is priced at $11.13, while CMOPF trades at $55.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 16.33, whereas CMOPF's P/E ratio is 5.93. In terms of profitability, SNPHY's ROE is +0.12%, compared to CMOPF's ROE of +0.14%. Regarding short-term risk, SNPHY and CMOPF have similar daily volatility (0.00).Check CMOPF's competition here
SNPHY vs TGRNF Comparison August 2025
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.8B. In comparison, TGRNF has a market cap of 851.7M. Regarding current trading prices, SNPHY is priced at $11.13, while TGRNF trades at $0.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 16.33, whereas TGRNF's P/E ratio is 11.08. In terms of profitability, SNPHY's ROE is +0.12%, compared to TGRNF's ROE of +0.09%. Regarding short-term risk, SNPHY is less volatile compared to TGRNF. This indicates potentially lower risk in terms of short-term price fluctuations for SNPHY.Check TGRNF's competition here
SNPHY vs JCRRF Comparison August 2025
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.8B. In comparison, JCRRF has a market cap of 636.1M. Regarding current trading prices, SNPHY is priced at $11.13, while JCRRF trades at $5.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 16.33, whereas JCRRF's P/E ratio is -20.08. In terms of profitability, SNPHY's ROE is +0.12%, compared to JCRRF's ROE of -0.01%. Regarding short-term risk, SNPHY and JCRRF have similar daily volatility (0.00).Check JCRRF's competition here
SNPHY vs MAYNF Comparison August 2025
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.8B. In comparison, MAYNF has a market cap of 284.4M. Regarding current trading prices, SNPHY is priced at $11.13, while MAYNF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 16.33, whereas MAYNF's P/E ratio is -3.50. In terms of profitability, SNPHY's ROE is +0.12%, compared to MAYNF's ROE of -0.35%. Regarding short-term risk, SNPHY and MAYNF have similar daily volatility (0.00).Check MAYNF's competition here
SNPHY vs PTKFY Comparison August 2025
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.8B. In comparison, PTKFY has a market cap of 18.6M. Regarding current trading prices, SNPHY is priced at $11.13, while PTKFY trades at $15.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 16.33, whereas PTKFY's P/E ratio is 17.46. In terms of profitability, SNPHY's ROE is +0.12%, compared to PTKFY's ROE of +0.15%. Regarding short-term risk, SNPHY and PTKFY have similar daily volatility (0.00).Check PTKFY's competition here
SNPHY vs PSYGF Comparison August 2025
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.8B. In comparison, PSYGF has a market cap of 78.2K. Regarding current trading prices, SNPHY is priced at $11.13, while PSYGF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 16.33, whereas PSYGF's P/E ratio is N/A. In terms of profitability, SNPHY's ROE is +0.12%, compared to PSYGF's ROE of +2.78%. Regarding short-term risk, SNPHY is less volatile compared to PSYGF. This indicates potentially lower risk in terms of short-term price fluctuations for SNPHY.Check PSYGF's competition here
SNPHY vs CRXTQ Comparison August 2025
SNPHY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNPHY stands at 3.8B. In comparison, CRXTQ has a market cap of 72.8K. Regarding current trading prices, SNPHY is priced at $11.13, while CRXTQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNPHY currently has a P/E ratio of 16.33, whereas CRXTQ's P/E ratio is -0.00. In terms of profitability, SNPHY's ROE is +0.12%, compared to CRXTQ's ROE of +0.33%. Regarding short-term risk, SNPHY and CRXTQ have similar daily volatility (0.00).Check CRXTQ's competition here